Global Ketorolac Tromethamine Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Publisher Name :
Date: 17-Jan-2019
No. of pages: 139

Ketorolac tromethamine, a nonsteroidal anti-inflammatory drug (NSAID), is indicated for the short-term (up to 5 days in adults) management of moderately severe acute pain that requires analgesia at the opioid level.

Scope of the Report:

The worldwide market for Ketorolac Tromethamine is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

This report focuses on the Ketorolac Tromethamine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

- Pfizer

- Omeros Corporation

- Egalet US Inc.

- Allergan

- Dr. Reddy's Laboratories

- Teva

- Mylan

- West Ward Pharmaceuticals

- Fresenius Kabi

- Apotex

- Sandoz

- Amphastar Pharmaceuticals

- Gland Pharma Limited

- Akorn

- Sun Pharmaceutical

- Sagent Pharmaceuticals

- Aurobindo Pharma

Market Segment by Regions, regional analysis covers

- North America (United States, Canada and Mexico)

- Europe (Germany, France, UK, Russia and Italy)

- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

- South America (Brazil, Argentina, Colombia etc.)

- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

- Injection

- Ophthalmic

- Nasal

- Oral tablet

Market Segment by Applications, can be divided into

- Short-term treatment of pain

- Ophthalmic Surgery

There are 15 Chapters to deeply display the global Ketorolac Tromethamine market.

Chapter 1, to describe Ketorolac Tromethamine Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Ketorolac Tromethamine, with sales, revenue, and price of Ketorolac Tromethamine, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Ketorolac Tromethamine, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Ketorolac Tromethamine market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Ketorolac Tromethamine sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Global Ketorolac Tromethamine Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Table of Contents

1 Market Overview
1.1 Ketorolac Tromethamine Introduction
1.2 Market Analysis by Type
1.2.1 Injection
1.2.2 Ophthalmic
1.2.3 Nasal
1.2.4 Oral tablet
1.3 Market Analysis by Applications
1.3.1 Short-term treatment of pain
1.3.2 Ophthalmic Surgery
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Business Overview
2.1.2 Ketorolac Tromethamine Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Pfizer Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Omeros Corporation
2.2.1 Business Overview
2.2.2 Ketorolac Tromethamine Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Omeros Corporation Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Egalet US Inc.
2.3.1 Business Overview
2.3.2 Ketorolac Tromethamine Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Egalet US Inc. Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Allergan
2.4.1 Business Overview
2.4.2 Ketorolac Tromethamine Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Allergan Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Dr. Reddy's Laboratories
2.5.1 Business Overview
2.5.2 Ketorolac Tromethamine Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Dr. Reddy's Laboratories Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Teva
2.6.1 Business Overview
2.6.2 Ketorolac Tromethamine Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Teva Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Mylan
2.7.1 Business Overview
2.7.2 Ketorolac Tromethamine Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Mylan Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 West Ward Pharmaceuticals
2.8.1 Business Overview
2.8.2 Ketorolac Tromethamine Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 West Ward Pharmaceuticals Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Fresenius Kabi
2.9.1 Business Overview
2.9.2 Ketorolac Tromethamine Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Fresenius Kabi Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Apotex
2.10.1 Business Overview
2.10.2 Ketorolac Tromethamine Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Apotex Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Sandoz
2.11.1 Business Overview
2.11.2 Ketorolac Tromethamine Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Sandoz Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Amphastar Pharmaceuticals
2.12.1 Business Overview
2.12.2 Ketorolac Tromethamine Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Amphastar Pharmaceuticals Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Gland Pharma Limited
2.13.1 Business Overview
2.13.2 Ketorolac Tromethamine Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Gland Pharma Limited Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 Akorn
2.14.1 Business Overview
2.14.2 Ketorolac Tromethamine Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Akorn Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 Sun Pharmaceutical
2.15.1 Business Overview
2.15.2 Ketorolac Tromethamine Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Sun Pharmaceutical Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.16 Sagent Pharmaceuticals
2.16.1 Business Overview
2.16.2 Ketorolac Tromethamine Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Sagent Pharmaceuticals Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.17 Aurobindo Pharma
2.17.1 Business Overview
2.17.2 Ketorolac Tromethamine Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Aurobindo Pharma Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Ketorolac Tromethamine Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Ketorolac Tromethamine Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Ketorolac Tromethamine Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Ketorolac Tromethamine Manufacturer Market Share in 2017
3.3.2 Top 6 Ketorolac Tromethamine Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Ketorolac Tromethamine Market Analysis by Regions
4.1 Global Ketorolac Tromethamine Sales, Revenue and Market Share by Regions
4.1.1 Global Ketorolac Tromethamine Sales and Market Share by Regions (2013-2018)
4.1.2 Global Ketorolac Tromethamine Revenue and Market Share by Regions (2013-2018)
4.2 North America Ketorolac Tromethamine Sales and Growth Rate (2013-2018)
4.3 Europe Ketorolac Tromethamine Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Ketorolac Tromethamine Sales and Growth Rate (2013-2018)
4.5 South America Ketorolac Tromethamine Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Ketorolac Tromethamine Sales and Growth Rate (2013-2018)
5 North America Ketorolac Tromethamine by Countries
5.1 North America Ketorolac Tromethamine Sales, Revenue and Market Share by Countries
5.1.1 North America Ketorolac Tromethamine Sales and Market Share by Countries (2013-2018)
5.1.2 North America Ketorolac Tromethamine Revenue and Market Share by Countries (2013-2018)
5.2 United States Ketorolac Tromethamine Sales and Growth Rate (2013-2018)
5.3 Canada Ketorolac Tromethamine Sales and Growth Rate (2013-2018)
5.4 Mexico Ketorolac Tromethamine Sales and Growth Rate (2013-2018)
6 Europe Ketorolac Tromethamine by Countries
6.1 Europe Ketorolac Tromethamine Sales, Revenue and Market Share by Countries
6.1.1 Europe Ketorolac Tromethamine Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Ketorolac Tromethamine Revenue and Market Share by Countries (2013-2018)
6.2 Germany Ketorolac Tromethamine Sales and Growth Rate (2013-2018)
6.3 UK Ketorolac Tromethamine Sales and Growth Rate (2013-2018)
6.4 France Ketorolac Tromethamine Sales and Growth Rate (2013-2018)
6.5 Russia Ketorolac Tromethamine Sales and Growth Rate (2013-2018)
6.6 Italy Ketorolac Tromethamine Sales and Growth Rate (2013-2018)
7 Asia-Pacific Ketorolac Tromethamine by Countries
7.1 Asia-Pacific Ketorolac Tromethamine Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Ketorolac Tromethamine Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Ketorolac Tromethamine Revenue and Market Share by Countries (2013-2018)
7.2 China Ketorolac Tromethamine Sales and Growth Rate (2013-2018)
7.3 Japan Ketorolac Tromethamine Sales and Growth Rate (2013-2018)
7.4 Korea Ketorolac Tromethamine Sales and Growth Rate (2013-2018)
7.5 India Ketorolac Tromethamine Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Ketorolac Tromethamine Sales and Growth Rate (2013-2018)
8 South America Ketorolac Tromethamine by Countries
8.1 South America Ketorolac Tromethamine Sales, Revenue and Market Share by Countries
8.1.1 South America Ketorolac Tromethamine Sales and Market Share by Countries (2013-2018)
8.1.2 South America Ketorolac Tromethamine Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Ketorolac Tromethamine Sales and Growth Rate (2013-2018)
8.3 Argentina Ketorolac Tromethamine Sales and Growth Rate (2013-2018)
8.4 Colombia Ketorolac Tromethamine Sales and Growth Rate (2013-2018)
9 Middle East and Africa Ketorolac Tromethamine by Countries
9.1 Middle East and Africa Ketorolac Tromethamine Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Ketorolac Tromethamine Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Ketorolac Tromethamine Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Ketorolac Tromethamine Sales and Growth Rate (2013-2018)
9.3 UAE Ketorolac Tromethamine Sales and Growth Rate (2013-2018)
9.4 Egypt Ketorolac Tromethamine Sales and Growth Rate (2013-2018)
9.5 Nigeria Ketorolac Tromethamine Sales and Growth Rate (2013-2018)
9.6 South Africa Ketorolac Tromethamine Sales and Growth Rate (2013-2018)
10 Global Ketorolac Tromethamine Market Segment by Type
10.1 Global Ketorolac Tromethamine Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Ketorolac Tromethamine Sales and Market Share by Type (2013-2018)
10.1.2 Global Ketorolac Tromethamine Revenue and Market Share by Type (2013-2018)
10.2 Injection Sales Growth and Price
10.2.1 Global Injection Sales Growth (2013-2018)
10.2.2 Global Injection Price (2013-2018)
10.3 Ophthalmic Sales Growth and Price
10.3.1 Global Ophthalmic Sales Growth (2013-2018)
10.3.2 Global Ophthalmic Price (2013-2018)
10.4 Nasal Sales Growth and Price
10.4.1 Global Nasal Sales Growth (2013-2018)
10.4.2 Global Nasal Price (2013-2018)
10.5 Oral tablet Sales Growth and Price
10.5.1 Global Oral tablet Sales Growth (2013-2018)
10.5.2 Global Oral tablet Price (2013-2018)
11 Global Ketorolac Tromethamine Market Segment by Application
11.1 Global Ketorolac Tromethamine Sales Market Share by Application (2013-2018)
11.2 Short-term treatment of pain Sales Growth (2013-2018)
11.3 Ophthalmic Surgery Sales Growth (2013-2018)
12 Ketorolac Tromethamine Market Forecast (2018-2023)
12.1 Global Ketorolac Tromethamine Sales, Revenue and Growth Rate (2018-2023)
12.2 Ketorolac Tromethamine Market Forecast by Regions (2018-2023)
12.2.1 North America Ketorolac Tromethamine Market Forecast (2018-2023)
12.2.2 Europe Ketorolac Tromethamine Market Forecast (2018-2023)
12.2.3 Asia-Pacific Ketorolac Tromethamine Market Forecast (2018-2023)
12.2.4 South America Ketorolac Tromethamine Market Forecast (2018-2023)
12.2.5 Middle East and Africa Ketorolac Tromethamine Market Forecast (2018-2023)
12.3 Ketorolac Tromethamine Market Forecast by Type (2018-2023)
12.3.1 Global Ketorolac Tromethamine Sales Forecast by Type (2018-2023)
12.3.2 Global Ketorolac Tromethamine Market Share Forecast by Type (2018-2023)
12.4 Ketorolac Tromethamine Market Forecast by Application (2018-2023)
12.4.1 Global Ketorolac Tromethamine Sales Forecast by Application (2018-2023)
12.4.2 Global Ketorolac Tromethamine Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

List of Tables and Figures

Figure Ketorolac Tromethamine Picture
Table Product Specifications of Ketorolac Tromethamine
Figure Global Sales Market Share of Ketorolac Tromethamine by Types in 2017
Table Ketorolac Tromethamine Types for Major Manufacturers
Figure Injection Picture
Figure Ophthalmic Picture
Figure Nasal Picture
Figure Oral tablet Picture
Figure Ketorolac Tromethamine Sales Market Share by Applications in 2017
Figure Short-term treatment of pain Picture
Figure Ophthalmic Surgery Picture
Figure United States Ketorolac Tromethamine Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Ketorolac Tromethamine Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Ketorolac Tromethamine Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Ketorolac Tromethamine Revenue (Value) and Growth Rate (2013-2023)
Figure France Ketorolac Tromethamine Revenue (Value) and Growth Rate (2013-2023)
Figure UK Ketorolac Tromethamine Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Ketorolac Tromethamine Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Ketorolac Tromethamine Revenue (Value) and Growth Rate (2013-2023)
Figure China Ketorolac Tromethamine Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Ketorolac Tromethamine Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Ketorolac Tromethamine Revenue (Value) and Growth Rate (2013-2023)
Figure India Ketorolac Tromethamine Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Ketorolac Tromethamine Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Ketorolac Tromethamine Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Ketorolac Tromethamine Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Ketorolac Tromethamine Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Ketorolac Tromethamine Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Ketorolac Tromethamine Revenue (Value) and Growth Rate (2013-2023)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Ketorolac Tromethamine Type and Applications
Table Pfizer Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Omeros Corporation Basic Information, Manufacturing Base and Competitors
Table Omeros Corporation Ketorolac Tromethamine Type and Applications
Table Omeros Corporation Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Egalet US Inc. Basic Information, Manufacturing Base and Competitors
Table Egalet US Inc. Ketorolac Tromethamine Type and Applications
Table Egalet US Inc. Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Allergan Basic Information, Manufacturing Base and Competitors
Table Allergan Ketorolac Tromethamine Type and Applications
Table Allergan Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Dr. Reddy's Laboratories Basic Information, Manufacturing Base and Competitors
Table Dr. Reddy's Laboratories Ketorolac Tromethamine Type and Applications
Table Dr. Reddy's Laboratories Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Teva Basic Information, Manufacturing Base and Competitors
Table Teva Ketorolac Tromethamine Type and Applications
Table Teva Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Mylan Basic Information, Manufacturing Base and Competitors
Table Mylan Ketorolac Tromethamine Type and Applications
Table Mylan Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table West Ward Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table West Ward Pharmaceuticals Ketorolac Tromethamine Type and Applications
Table West Ward Pharmaceuticals Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Fresenius Kabi Basic Information, Manufacturing Base and Competitors
Table Fresenius Kabi Ketorolac Tromethamine Type and Applications
Table Fresenius Kabi Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Apotex Basic Information, Manufacturing Base and Competitors
Table Apotex Ketorolac Tromethamine Type and Applications
Table Apotex Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Sandoz Basic Information, Manufacturing Base and Competitors
Table Sandoz Ketorolac Tromethamine Type and Applications
Table Sandoz Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Amphastar Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Amphastar Pharmaceuticals Ketorolac Tromethamine Type and Applications
Table Amphastar Pharmaceuticals Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Gland Pharma Limited Basic Information, Manufacturing Base and Competitors
Table Gland Pharma Limited Ketorolac Tromethamine Type and Applications
Table Gland Pharma Limited Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Akorn Basic Information, Manufacturing Base and Competitors
Table Akorn Ketorolac Tromethamine Type and Applications
Table Akorn Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Sun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Sun Pharmaceutical Ketorolac Tromethamine Type and Applications
Table Sun Pharmaceutical Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Sagent Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Sagent Pharmaceuticals Ketorolac Tromethamine Type and Applications
Table Sagent Pharmaceuticals Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table Aurobindo Pharma Ketorolac Tromethamine Type and Applications
Table Aurobindo Pharma Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Ketorolac Tromethamine Sales by Manufacturer (2016-2017)
Figure Global Ketorolac Tromethamine Sales Market Share by Manufacturer in 2016
Figure Global Ketorolac Tromethamine Sales Market Share by Manufacturer in 2017
Table Global Ketorolac Tromethamine Revenue by Manufacturer (2016-2017)
Figure Global Ketorolac Tromethamine Revenue Market Share by Manufacturer in 2016
Figure Global Ketorolac Tromethamine Revenue Market Share by Manufacturer in 2017
Figure Top 3 Ketorolac Tromethamine Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Ketorolac Tromethamine Manufacturer (Revenue) Market Share in 2017
Figure Global Ketorolac Tromethamine Sales and Growth Rate (2013-2018)
Figure Global Ketorolac Tromethamine Revenue and Growth Rate (2013-2018)
Table Global Ketorolac Tromethamine Sales by Regions (2013-2018)
Table Global Ketorolac Tromethamine Sales Market Share by Regions (2013-2018)
Table Global Ketorolac Tromethamine Revenue by Regions (2013-2018)
Figure Global Ketorolac Tromethamine Revenue Market Share by Regions in 2013
Figure Global Ketorolac Tromethamine Revenue Market Share by Regions in 2017
Figure North America Ketorolac Tromethamine Sales and Growth Rate (2013-2018)
Figure Europe Ketorolac Tromethamine Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Ketorolac Tromethamine Sales and Growth Rate (2013-2018)
Figure South America Ketorolac Tromethamine Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Ketorolac Tromethamine Sales and Growth Rate (2013-2018)
Figure North America Ketorolac Tromethamine Revenue and Growth Rate (2013-2018)
Table North America Ketorolac Tromethamine Sales by Countries (2013-2018)
Table North America Ketorolac Tromethamine Sales Market Share by Countries (2013-2018)
Figure North America Ketorolac Tromethamine Sales Market Share by Countries in 2013
Figure North America Ketorolac Tromethamine Sales Market Share by Countries in 2017
Table North America Ketorolac Tromethamine Revenue by Countries (2013-2018)
Table North America Ketorolac Tromethamine Revenue Market Share by Countries (2013-2018)
Figure North America Ketorolac Tromethamine Revenue Market Share by Countries in 2013
Figure North America Ketorolac Tromethamine Revenue Market Share by Countries in 2017
Figure United States Ketorolac Tromethamine Sales and Growth Rate (2013-2018)
Figure Canada Ketorolac Tromethamine Sales and Growth Rate (2013-2018)
Figure Mexico Ketorolac Tromethamine Sales and Growth Rate (2013-2018)
Figure Europe Ketorolac Tromethamine Revenue and Growth Rate (2013-2018)
Table Europe Ketorolac Tromethamine Sales by Countries (2013-2018)
Table Europe Ketorolac Tromethamine Sales Market Share by Countries (2013-2018)
Table Europe Ketorolac Tromethamine Revenue by Countries (2013-2018)
Figure Europe Ketorolac Tromethamine Revenue Market Share by Countries in 2016
Figure Europe Ketorolac Tromethamine Revenue Market Share by Countries in 2017
Figure Germany Ketorolac Tromethamine Sales and Growth Rate (2013-2018)
Figure UK Ketorolac Tromethamine Sales and Growth Rate (2013-2018)
Figure France Ketorolac Tromethamine Sales and Growth Rate (2013-2018)
Figure Russia Ketorolac Tromethamine Sales and Growth Rate (2013-2018)
Figure Italy Ketorolac Tromethamine Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Ketorolac Tromethamine Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Ketorolac Tromethamine Sales by Countries (2013-2018)
Table Asia-Pacific Ketorolac Tromethamine Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Ketorolac Tromethamine Sales Market Share by Countries 2017
Table Asia-Pacific Ketorolac Tromethamine Revenue by Countries (2013-2018)
Figure Asia-Pacific Ketorolac Tromethamine Revenue Market Share by Countries 2017
Figure China Ketorolac Tromethamine Sales and Growth Rate (2013-2018)
Figure Japan Ketorolac Tromethamine Sales and Growth Rate (2013-2018)
Figure Korea Ketorolac Tromethamine Sales and Growth Rate (2013-2018)
Figure India Ketorolac Tromethamine Sales and Growth Rate (2013-2018)
Figure Southeast Asia Ketorolac Tromethamine Sales and Growth Rate (2013-2018)
Figure South America Ketorolac Tromethamine Revenue and Growth Rate (2013-2018)
Table South America Ketorolac Tromethamine Sales by Countries (2013-2018)
Table South America Ketorolac Tromethamine Sales Market Share by Countries (2013-2018)
Figure South America Ketorolac Tromethamine Sales Market Share by Countries in 2017
Table South America Ketorolac Tromethamine Revenue by Countries (2013-2018)
Table South America Ketorolac Tromethamine Revenue Market Share by Countries (2013-2018)
Figure South America Ketorolac Tromethamine Revenue Market Share by Countries in 2017
Figure Brazil Ketorolac Tromethamine Sales and Growth Rate (2013-2018)
Figure Argentina Ketorolac Tromethamine Sales and Growth Rate (2013-2018)
Figure Colombia Ketorolac Tromethamine Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Ketorolac Tromethamine Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Ketorolac Tromethamine Sales by Countries (2013-2018)
Table Middle East and Africa Ketorolac Tromethamine Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Ketorolac Tromethamine Sales Market Share by Countries in 2017
Table Middle East and Africa Ketorolac Tromethamine Revenue by Countries (2013-2018)
Table Middle East and Africa Ketorolac Tromethamine Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Ketorolac Tromethamine Revenue Market Share by Countries in 2013
Figure Middle East and Africa Ketorolac Tromethamine Revenue Market Share by Countries in 2017
Figure Saudi Arabia Ketorolac Tromethamine Sales and Growth Rate (2013-2018)
Figure UAE Ketorolac Tromethamine Sales and Growth Rate (2013-2018)
Figure Egypt Ketorolac Tromethamine Sales and Growth Rate (2013-2018)
Figure Nigeria Ketorolac Tromethamine Sales and Growth Rate (2013-2018)
Figure South Africa Ketorolac Tromethamine Sales and Growth Rate (2013-2018)
Table Global Ketorolac Tromethamine Sales by Type (2013-2018)
Table Global Ketorolac Tromethamine Sales Share by Type (2013-2018)
Table Global Ketorolac Tromethamine Revenue by Type (2013-2018)
Table Global Ketorolac Tromethamine Revenue Share by Type (2013-2018)
Figure Global Injection Sales Growth (2013-2018)
Figure Global Injection Price (2013-2018)
Figure Global Ophthalmic Sales Growth (2013-2018)
Figure Global Ophthalmic Price (2013-2018)
Figure Global Nasal Sales Growth (2013-2018)
Figure Global Nasal Price (2013-2018)
Figure Global Oral tablet Sales Growth (2013-2018)
Figure Global Oral tablet Price (2013-2018)
Table Global Ketorolac Tromethamine Sales by Application (2013-2018)
Table Global Ketorolac Tromethamine Sales Share by Application (2013-2018)
Figure Global Ophthalmic Surgery Sales Growth (2013-2018)
Figure Global Ketorolac Tromethamine Sales, Revenue and Growth Rate (2018-2023)
Table Global Ketorolac Tromethamine Sales Forecast by Regions (2018-2023)
Table Global Ketorolac Tromethamine Market Share Forecast by Regions (2018-2023)
Figure North America Sales Ketorolac Tromethamine Market Forecast (2018-2023)
Figure Europe Sales Ketorolac Tromethamine Market Forecast (2018-2023)
Figure Asia-Pacific Sales Ketorolac Tromethamine Market Forecast (2018-2023)
Figure South America Sales Ketorolac Tromethamine Market Forecast (2018-2023)
Figure Middle East and Africa Sales Ketorolac Tromethamine Market Forecast (2018-2023)
Table Global Ketorolac Tromethamine Sales Forecast by Type (2018-2023)
Table Global Ketorolac Tromethamine Market Share Forecast by Type (2018-2023)
Table Global Ketorolac Tromethamine Sales Forecast by Application (2018-2023)
Table Global Ketorolac Tromethamine Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs